| Marina Tompkins, CRNA | |
|
400 Wabash Ave, Akron, OH 44307-2433 | |
| (330) 344-6000 | |
| Not Available |
| Full Name | Marina Tompkins |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 400 Wabash Ave, Akron, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003884362 | NPI | - | NPPES |
| 000000383966 | Other | OH | OH ANTHEM PIN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RN321848 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Marina Tompkins, CRNA 224 W Exchange St, Suite 360, Akron, OH 44302-1704 Ph: (330) 344-6401 | Marina Tompkins, CRNA 400 Wabash Ave, Akron, OH 44307-2433 Ph: (330) 344-6000 |
News Archive
Pregnant women who contract the H1N1 flu strain are at risk for obstetrical complications including fetal distress, premature delivery, emergency cesarean delivery and fetal death, according to a report in the May 24 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
To provide appropriate insurance coverage and medical care for acquired brain injury survivors in the state, the Brain Injury Association of California (BIACAL), is sponsoring Senate Bill 190 (Beall, D-San Jose), the Brain Injury Access to Rehabilitation Act of 2015 (BIARA).
Representatives of Caritas Christi Health Care, the private equity firm seeking to buy it, and the attorney general's office are working on a tentative agreement to protect the retirement plans of 13,000 employees and keep the chain's hospitals open for at least five years.
Though the FDA's Monday approval of the antiretroviral drug Truvada for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV infection among people at risk of contracting the virus "was hailed by many as an important step in the fight against AIDS, concerns that people will incorrectly use the drug - potentially spurring drug resistance - led others to blast the agency for not laying down tougher rules," the Wall Street Journal's "Health Blog" writes.
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the final data from the ENTRANCE Phase IIa trial in inflammatory bowel disease with vidofludimus, an oral inhibitor of interleukin-17 release and DHODH, including the secondary endpoints comprising the analysis of CDAI and CAI disease scores, change of prednisolone intake and threshold doses, safety, pharmacokinetics and biomarkers.
› Verified 2 days ago
Kevin N Brake, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2215 E Waterloo Rd, Ste 313, Akron, OH 44312 Phone: 330-208-2720 Fax: 330-208-2721 | |
Kevin Wires, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-6000 | |
Andrew P Kochan, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-1000 | |
Brian Nash, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 141 N Forge St, Akron, OH 44304 Phone: 330-375-3000 | |
Kristen Waltz, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-3765 | |
William C Stanger, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 190 N Union St, Ste 104, Akron, OH 44304 Phone: 330-253-9145 Fax: 330-253-6222 |